Place of provision rules: clinical services tied to goods supplied by an overseas recipient fall under Rule 4; stand-alone research does not.

Clinical Pharmacology services performed on formulations physically made available by an overseas recipient fall within Rule 4(a) of the Place of Provision of Services Rules, 2012, because the service is rendered in respect of goods and is deemed supplied where actually performed. Clinical Research services are treated the same way when directly connected to such formulations and are taxable under Rule 4. However, stand-alone Clinical Research services not rendered in relation to those goods, and not involving the recipient's physical presence, fall outside Rule 4 and are governed by the general rule under Rule 3.

---

---

Issues: (i) Whether proposed Clinical Pharmacology services are taxable under Rule 4(a) of the Place of Provision of Services Rules, 2012 when the goods used for the clinical studies are made physically available by the foreign recipient to the applicant in India. (ii) Whether Clinical Research services are taxable under Rule 4 of the Place of Provision of Services Rules, 2012 when rendered in respect of such goods, and whether stand-alone Clinical Research services fall outside Rule 4 and are governed by Rule 3.

Issue (i): Whether proposed Clinical Pharmacology services are taxable under Rule 4(a) of the Place of Provision of Services Rules, 2012 when the goods used for the clinical studies are made physically available by the foreign recipient to the applicant in India.

Analysis: Rule 4(a) fixes the place of provision at the location where the service is actually performed when the service is provided in respect of goods that are required to be made physically available by the recipient to the provider. The proposed clinical pharmacology studies were to be conducted on formulations supplied by customers outside India, and the service was directly in relation to those formulations. The requirement that the goods be specific individual goods, and not a class of goods, was not accepted. The service therefore satisfied the conditions of Rule 4(a).

Conclusion: The Clinical Pharmacology services are taxable under the Act in terms of Rule 4(a) of the Place of Provision of Services Rules, 2012.

Issue (ii): Whether Clinical Research services are taxable under Rule 4 of the Place of Provision of Services Rules, 2012 when rendered in respect of such goods, and whether stand-alone Clinical Research services fall outside Rule 4 and are governed by Rule 3.

Analysis: Clinical Research services, when rendered in connection with formulations made physically available by the foreign recipient and used in the clinical process, were treated as services in respect of goods and therefore falling within Rule 4. By contrast, where Clinical Research was provided independently and not in relation to such formulations, neither Rule 4(a) nor Rule 4(b) applied, because the services were not in the physical presence of the recipient or a person acting for the recipient. In that situation, the place of provision was treated as outside India under Rule 3.

Conclusion: Clinical Research services rendered in respect of goods made physically available are taxable under the Act in terms of Rule 4, while stand-alone Clinical Research services are not taxable under the Act in terms of Rule 3.

Final Conclusion: The ruling holds that Clinical Pharmacology, and Clinical Research when performed in relation to formulations supplied by the overseas recipient, fall within Rule 4 and are taxable, but stand-alone Clinical Research not connected with such goods falls outside Rule 4 and is treated as non-taxable by reference to Rule 3.

Ratio Decidendi: Where a service is rendered in respect of goods required to be physically made available by the recipient to the provider, the place of provision is where the service is actually performed and Rule 4 prevails over the general rule; services unconnected with such goods and lacking the recipient's physical presence fall under the general place-of-provision rule.

---